People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Polarityte, Inc. | — | Biotechnology | Series B | $24.0M | $69.4M | 2022 |
| Omeza Holdings, Inc. | — | Other Health Care | Series A | $13.8M | $3.7M | 2024 |
Richard Hague at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Hague on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Gorlin | 1 | 11 |
| MICHAEL BRAUSER | 1 | 6 |
| Barry Honig | 1 | 6 |
| Thomas Gardner | 1 | 6 |
| Peter Cohen | 1 | 3 |
| Robert Essner | 1 | 3 |
| John Stetson | 1 | 3 |
| Mohit Bhansali | 1 | 2 |
| AG Lafley | 1 | 2 |
| Cynthia Flowers | 1 | 2 |
| Joel Morganroth | 1 | 2 |
| Ronald Gelbman | 1 | 2 |
| Jon Mogford | 1 | 2 |
| Jeffrey Dyer | 1 | 1 |
| Cameron Hoyler | 1 | 1 |
| Jacob Patterson | 1 | 1 |
| Denver Lough | 1 | 1 |
| David Seaburg | 1 | 1 |
| Willie Bogan | 1 | 1 |
| Michael Beeghley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.